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Abstract: The proliferation and motile activity of prostate epithelial (Pnt2) and cancer cells (DU-145;
PC-3) in the presence of bioavailable compounds from green coffee beans (GCB), wholemeal wheat
bread (WMWB), and its GCB-fortified variant were analyzed. The considerable cytostatic and
anti-invasive activity of GCB extracts was correlated with its phenolic contents. WMWB extract
contained significantly lower levels of phenolics but still displayed relatively high cytostatic activity.
However, the cytostatic properties of WMWB compounds were hardly augmented by 3% GCB flour
supplementation. The cytoprotective activity of the WMWB compounds exerts a negative impact on
the cytostatic activity of GCB compounds. These data confirm the relatively high chemopreventive
potential of GCB. However, they also indicate that subtle interactions between bioavailable compounds
in GCB and WMWB can negatively affect the nutraceutic potential of the fortified bread. Apparently,
gastrointestinal processing differentially regulates the availability of individual compounds and
affects the balance between the cytostatic and cytoprotective activity of the whole product. Our data
show that comprehensive research is necessary before the fortification of a specific carrier with a
specific supplement can be recommended.
Keywords: coffee beans; wholemeal bread; prostate cancer; gastrointestinal digestion; cytoprotection
1. Introduction
Coffee beans are commonly used as a raw material for hot drinks and beverages. Numerous
bioactive compounds in green coffee beans (GCB) may account for their normalizing effect on human
metabolism [1]. Accordingly, flour made from GCB is considered a promising food fortifier. It can enrich
the fortified products with a spectrum of phenolic compounds [2–6]. Phenolics represent a diverse
group of secondary plant metabolites. In particular, GCB phenolic compounds exhibit antioxidant,
antimutagenic, and anti-in. flammatory properties in vitro. These properties result from the antiradical
and reducing potential of the compounds and from their ability to modify the activity of kinases,
phosphates, and pro-oxidative enzymes [5]. Consequently, the antioxidative properties of phenolics
are responsible for their interference with intracellular oxidative stress and reactive oxygen species
(ROS)–dependent signaling pathways, thus accounting for their cytoprotective activity. Recently, the
fortification of bread products has been proposed as a method of daily diet enrichment with phenolic
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compounds. These facts prompted us to speculate about the introduction of GCB-fortified bread into
the daily diet [7].
Attempts to introduce GCB phenolics in the daily human diet require in-depth knowledge on
the cell-specific consequences of their bioactivity [1,8]. They cannot be estimated without careful
examination of the effects of GCB phenolics on the physiology of normal and cancer cells. We
have previously shown that the addition of GCB flour into wholemeal wheat bread (WMWB)
increases the amounts of bioaccessible and bioavailable phenolics in the product. It also enhanced its
antioxidative potency [6]. Furthermore, the fortification of white bread with broccoli sprouts increased
its chemopreventive potential. This was illustrated by the prominent cytostatic response of stomach
cancer cells to extracts from a broccoli-sprout-supplemented product. In the same experimental model,
onion skins considerably augmented the phenolic content and cytostatic activity of white bread [9].
The beneficial effects of bread fortification are determined by numerous factors (including the quality
and quantity of the fortifier), by the additive and subtractive effects of the activities of bread and
GCB phenolics, and by the collective reactivity of multicellular systems to these compounds. This
justifies intensified research on the interactions between GCB and WMWB compounds and on their
consequences in vivo and in vitro.
GCB phenolics are potentially bioaccessible and bioavailable in vitro; however, the interactions
between these compounds and the bread matrix can differentially affect their release during
gastrointestinal processing [6,10]. These interactions affect the bioavailability of individual compounds
and their relative content, thus having a potential impact on the bioactivity of the whole product. This
may be crucial for the chemopreventive activity of the product. According to a recent meta-analysis,
the relative risk of prostate cancer in regular coffee drinkers was considerably reduced as compared
to that in coffee non-drinkers [11,12]. Therefore, we focused on the chemopreventive potential of
GCB-supplemented bread against prostate cancer in terms of the bioavailability of its compounds. We
analyzed the proliferation and motility of prostate cancer (DU-145; PC-3) and epithelial (Pnt2) cells in
the presence of extracts from GCB flour, raw WMWB, and from a GCB-fortified product. Furthermore,
we compared the cytostatic, anti-invasive, and cytoprotective activities of the extract subjected to
simulated mastication, gastrointestinal digestion, and absorption in vitro. Such an approach enabled
us to address the possible consequences of bread fortification on the anti-cancer bioactivity of the
product in terms of the bioavailability of GCB and WMWB phenolics.
2. Materials and Methods
2.1. Gastrointestinal Processing and Preparation of Extracts
Plant Materials
Green coffee (Coffea arabica) beans were received from Cofeina Romuald Zalewski, Marki, Poland.
Flour from green coffee beans (moisture content 11.5 mg/100 g) was prepared according to Dziki et al.,
2015 [4]. Wholemeal wheat flour (WF) was purchased from a local supermarket in Lublin, Poland
(protein, ash, and moisture contents: 14 mg/100 g, 1.89 mg/100 g, and 13.6 mg/100 g, respectively).
2.2. Bread Preparation
The control bread (C) was prepared from WF. For GC1, GC2, GC3, GC4, and GC5 production,
the flour was replaced with GCB flour at levels of 1 g/100 g, 2 g/100 g, 3 g/100 g, 4 g/100 g, 5 g/100 g,
respectively. In addition, 6 g of instant yeast and 12 g of salt were used.
The amount of water necessary for the preparation of the dough was determined using a
Farinograph (Brabender, Duisburg, Germany). After fermentation, the pieces of dough were divided
(300 g) and baked in an electric oven (Sveba Dahlen, Fristad Sweden) at 230 ◦C for 30 min. After
baking, the bread was stored at room temperature for 1 h, packed in polypropylene bags and stored at
21 ◦C for 24 h, freeze-dried, and comminuted [4].
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2.3. Gastrointestinal Processing and Preparation of Extracts
The buffer extract and extracts after simulated digestion and absorption were prepared according
to Minekus et al. [13] with some modifications [14].
2.4. Cell Cultures and Medium Supplementation
Human prostate cancer DU-145 (HTB-81) and PC3 cells (CRL-1435, both from American Type
Culture Colection (ATCC, Manassas, VA, USA) were routinely cultivated in Dulbecco's-Modified
Eagle's medium-F12 Ham (DMEM-F12) medium supplemented with 10% fetal bovine serum (FBS) and
antibiotics (gentamycin, Krka d.d., Novo Mesto, Slovenia) in standard conditions (37 ◦C, 5% CO2) [15].
Epithelioid PNT2 prostate cells (Sigma-Aldrich St. Louis, MO, USA, cat. No. 95012613) were cultured
in RPMI medium supplemented with 10% FBS. For endpoint experiments, cells were harvested upon
confluence with 0.25% trypsin in PBS (Sigma-Aldrich; [16]), and the cells were seeded into culture
dishes at the densities given below and incubated for 24 hours. Afterwards, the culture medium was
replaced with a new one supplemented with the relevant extract. Lyophilized extracts from saline
buffer masticated (SB), gastrointestinally digested (GD), and gastrointestinally digested/absorbed
(GDA) products were dissolved in the medium to reach final extract concentrations equivalent to 150
and 250 g of the product per 75 kg of body mass.
2.5. Cell Proliferation
For cell proliferation tests, the cells were harvested with trypsinization and seeded into 12-well
plates in culture medium supplemented with 10% FBS (Corning, NY, USA) at an initial density of 5.5 ×
103 cells/cm2. Then, the cells were incubated for 24 h at 37 ◦C before the medium was replaced with
a fresh one without (vehicle control) or with the relevant extract (applied at the concentration given
in the text). After 72 h of incubation, the cells were harvested by trypsinization and counted using a
Coulter Z2 Beckman counter. Three independent experiments were performed for each condition [17].
2.6. Cell Motility
For the analyses of cell movement, the cells were seeded into 12–well plates (Corning) at a density
of 104 cells/cm2. After 24 h, the medium was replaced with new medium without (control) or with the
relevant extract applied at the concentration given in the text. Time-lapse recordings of cell movement
were performed after 72 h incubation of the cells in the presence of the extracts at 37 ◦C and in 5% CO2
atmosphere using an inverted Leica DMI6000B microscope equipped with IMC optics and a cooled
digital DFC360FX CCD camera. The cell trajectories were constructed on the basis of 72 centroid
positions recorded over 480 minutes at 5 min time intervals using a dry 10×, NA-0.75 objective. They
were presented in circular diagrams with the starting point of each trajectory situated at the plot center.
For each data point measured, the trajectories of 50 cells were analyzed. The total length of the cell
trajectory (µm) and total length of cell displacement (i.e., the distance from the starting point directly
to the cell’s final position; µm) were quantified using the Hiro program (written by W. Czapla) as
described [17,18]. Three independent experiments were performed for each condition.
2.7. Phenolics Content
The total phenols content (TPC) was estimated according to Singleton and Rossi [19]. The
amount of total phenolics was expressed as gallic acid equivalent (GAE) per gram of dry weight (DW)
[mgGAE/g DW]. The values in the plots represent theoretical concentrations of individual compounds
in the culture medium for the extract dilution equivalent to 250 g of product per 75 kg.
2.8. Analysis of Caffeine and Phenolic acids
Samples were analyzed using a Varian ProStar high-performance liquid chromatography (HPLC)
system separation module (Varian, Palo Alto, CA, USA) equipped with a Varian ChromSpher C18
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reverse-phase column (250 mm, 4.6 mm) and ProStar diode-array detector DAD detector according to
a previously described method [20]. Liquid Chromatography Electrospray Ionization Tandem Mass
Spectrometric LC-ESI-MS/MS analysis of phenolic acids was performed as previously described [21].
2.9. Xanthine Oxidase Inhibition
Xanthine oxidase inhibition (XOI) activities were estimated according to Sweeney, Wyllie, Shalliker,
and Markham, 2001 [22]. Xanthine was used as the XO substrate. Inhibitory activity is expressed as
efficient concentration -IC50: the sample concentration (mg DW/ml) required to obtain 50% activity.
2.10. Statistics
Experimental data are presented as means ± standard deviation (SD) for biochemical analyses
and means ± standard error of the mean (SEM) for anticancer activity assays. In biochemical analyses,
statistical significance was estimated with Tukey’s test (for the data obtained from three independent
samples of each extract in three parallel experiments; n = 9). For the estimation of the effect of extracts
on cell proliferation, the results from three independent experiments performed in triplicate (n = 9)
were subjected to statistical analyses using Mann-Whitney’s U-test. For the estimation of the effect of
extracts on cell motility, the trajectories of 50 cells from three independent experiments (n = 50) were
subjected to statistical analyses using Mann-Whitney’s U-test. Unless stated otherwise, the statistical
tests were performed at a significance level of 0.05. Statistical tests were performed using Statistica 6.0
software (StatSoft, Inc., Tulsa, Oklahoma, USA).
3. Results and Discussion
3.1. Bioavailable GCB Compounds Exert Cytostatic Effects on Prostate Cancer Cells
A multi-step protocol based on the simulated mastication (SB), gastrointestinal digestion (GD),
and absorption (GDA) of fortified foods in vitro imitates their digestive processing and the differential
penetration of natural biological barriers by their compounds. Their biological activity in cellular
systems can be assessed after the administration of SB, GD, and GDA extracts to cell culture media at
physiologically relevant concentrations. In this study, we applied the extracts at the concentrations
equivalent to 150 and 250 g of the fortified product per 75 kg of human body weight (for details,
see Section 2). The GDA_GCB-supplemented medium contained relatively high levels of phenolics,
including caffeic, ferulic, and caffeoquinic acids and caffeine (Figure 1A). It was also characterized
by considerable antioxidative activity and an inhibitory effect of the extract on xanthine oxidase (XO)
activity [21] (Figure 1B). Redox- and XO-dependent signaling pathways are crucial for effective cell
proliferation and motility. To estimate the potential of GCB for the chemoprevention of prostate
carcinogenesis, we further analyzed the proliferation and motility of human prostate DU145 cells in
the presence of gastrointestinally digested and absorbed (GDA) GCB extract.
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to 250 g of product per 75 kg of body weight. Bar graphs show theoretical medium concentrations of 
the compounds calculated on the basis of their content in the extract. (B) GCB were processed as 
above, and the antioxidative and xanthine oxidase (XO) inhibitory activity of the extracts was 
estimated. (C) DU145 cells were seeded at the density of 104/cm2 and cultivated for 24 h before 
gastrointestinally digested/absorbed (GDA) GCB extracts were administered along with 10% fetal 
bovine serum (FBS)-supplemented culture medium. Cell proliferation was measured after 72 h of 
incubation with a Coulter counter and compared to the control ( = 100%) Scale bar: 100 μm. (D) 
DU145 cells were seeded at the density of 104/cm2, then cultivated for 24 h and treated with GDE 
GCB extract for 72 h, and cell motility was analyzed via time-lapse videomicroscopy. Cell trajectories 
are presented in circular diagrams with the starting point of each trajectory situated at the plot center 
(N = 50). The bar graph shows averaged cell motility. All results are representative of at least three 
independent experiments performed in triplicate (N > 9). The values designated by the different 
letters (A) are statistically significantly different. p values in B and C were calculated using the 
non-parametric Mann–Whitney test, **p ≤ 0.001, **p ≤ 0.001. Note the cytostatic and anti-invasive 
effect of bioavailable GCB compounds on DU145 cells. 
Strong, dose-dependent inhibition of DU145 proliferation was observed in the presence of 
GDA_GCB extract (Figure 1C). This effect was accompanied by the inhibition of DU145 motility 
(Figure 1D). Previously, a corresponding cytoprotective effect of green coffee was observed in a 
human HepG2 cell model [23]. Our data suggest relatively strong anti-carcinogenic potential of the 
bioavailable GCB compounds. They indicate that GCB can be applied for prostate cancer 
chemoprevention, which justifies their implementation in the daily diet of humans.  
3.2. GCB Supplementation Slightly Affects the Cytostatic Properties of Bioavailable WMWB 
Compounds  
Fortification with GCB flour is an effective way of improving the pro-healthy properties of 
WMWB and increasing the daily dietary intake of GCB compounds, as previously shown for 
broccoli sprouts and onion skins [9]. Actually, WMWB does not contain bioavailable caffeine, 
caffeoquinic acids, or caffeic acid. Among the tested phenolics, the presence of syringic acid, vanillic 
acid, and (+) catechin was detected in the GDA_WMWB extract. These compounds reached 
Figure 1. Bioavailable compounds in green coffee beans (GCB) exert cytostatic effects on prostate
cancer DU145 cells. (A) GCB were subjected to simulated gastrointestinal digestion/absorption in vitro
(see Section 2), and the extract was applied to the culture medium at a concentration equivalent to
250 g of product per 75 kg of body weight. Bar graphs show theoretical medium concentrations
of the compounds calculated on the basis of their content in the extract. (B) GCB were processed
as above, and the antioxidative and xanthine oxidase (XO) inhibitory activity of the extracts was
estimated. (C) DU145 cells were seeded at the density of 104/cm2 and cultivated for 24 h before
gastrointestinally digested/absorbed (GDA) GCB extracts were administered along with 10% fetal
bovine serum (FBS)-supplemented culture medium. Cell proliferation was measured after 72 h of
incubation with a Coulter counter and compared to the control (= 100%) Scale bar: 100 µm. (D) DU145
cells were seeded at the density of 104/cm2, then cultivated for 24 h and treated with GDE GCB extract
for 72 h, and cell motility was analyzed via time-lapse videomicroscopy. Cell trajectories are presented
in circular diagrams with the starting point of each trajectory situated at the plot center (N = 50). The
bar graph shows averaged cell motility. All results are representative of at least three independent
experiments performed in triplicate (N > 9). The values designated by the different letters (A) are
statistically significantly different. p values in B and C were calculated using the non-parametric
Mann–Whitney test, **p ≤ 0.001, **p ≤ 0.001. Note the cytostatic and anti-invasive effect of bioavailable
GCB compounds on DU145 cells.
Strong, dose-dependent inhibition of DU145 proliferation was observed in the presence of
GDA_GCB extract (Figure 1C). This effect was accompanied by the inhibition of DU145 motility
(Figure 1D). Previously, a corresponding cytoprotective effect of green coffee was observed in a human
HepG2 cell model [23]. Our data suggest relatively strong anti-carcinogenic potential of the bioavailable
GCB compounds. They indicate that GCB can be applied for prostate cancer chemoprevention, which
justifies their implementation in the daily diet of humans.
3.2. GCB Supplementation Slightly Affects the Cytostatic Properties of Bioavailable WMWB Compounds
Fortification with GCB flour is an effective way of improving the pro-healthy properties of WMWB
and increasing the daily dietary intake of GCB compounds, as previously shown for broccoli sprouts
and onion skins [9]. Actually, WMWB does not contain bioavailable caffeine, caffeoquinic acids, or
caffeic acid. Among the tested phenolics, the presence of syringic acid, vanillic acid, and (+) catechin
was detected in the GDA_WMWB extract. These compounds reached concentrations between 0.4
and 1.2 µM in the supplemented culture medium (Figure 2A). The bioavailable WMWB compounds
displayed relatively high antioxidative potential and a negligible inhibitory effect on xanthine oxidase
(XO) activity (Figure 2B). Not surprisingly, the relatively low phenolic content of GDA_WMWB extract
was considerably enhanced upon the fortification of WMWB with 3% GCB flour. GCB supplementation
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considerably increased the total content of bioavailable phenolics and augmented the antioxidative
activity of the GDA_3%C_WMWB extract. For instance, the concentrations of caffeine, caffeic acid,
caffeoquinic acid, and ferulic acid in the culture medium supplemented with this extract reached ca.
0.1–10% of the corresponding values estimated for the medium supplemented with GDA_GCB extract.
Therefore, it was surprising to see that the inhibitory effects of bioavailable WMWB compounds on
DU145 motility (Figure 2C) and proliferation (Figure 2D) were only slightly affected by 3% GDA
supplementation. On the other hand, the activity of the GCB flour compounds was apparently retained
in the fortified product, as illustrated by the enhanced anti-invasive activity of the GDA_3%C_WMWB
medium (Figure 2C).
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Figure 2. Bioactivity of bioavailable phenolics fro raw wholemeal wheat bread (WMWB) and from
its variant fortified with 3% GCB flour. ( ) Ra and 3 CB_WMWB were subjected to simulated
gastrointestinal digestio /absor tio in vitro, and the extract was applied to the culture edium
at a concentration equivalent to 250 g of product per 75 kg of body weight. Bar graphs show the
theoretical medium concentrati unds calculated on the ba is of their content in the
extract. (B) GCB were proces t e antioxidative and XO inh bitory activity of the
extracts was estimated. (C) DU14 c l at a density of 104/cm2, cultivated for 24 h, and
treated with GDE GCB extract for 72 h, and cell motility was analyzed via time-lapse video icroscopy.
Cell trajectories are presented in circular diagrams with the starting point of each traject ry situated at
the plot center (N = 50). The bar graph shows avera ed cell motility. (D) DU145 cells were seeded
at a density of 104/cm2 and cultivated for 24 h before GDA extracts of WMWB and of its fortified
variant were administered along with 10% fetal bovine serum (FBS)-supple ented culture medium.
Cell proliferation was measured after 72 h of incubation with a Coulter counter and compared to
the control (= 100%). Scale bar: 100 µm. All results are representative of at least three independent
experiments performed in triplicate (N > 9). The values designated by the different letters (A and B)
are statistically significantly different. p values in C and D were calculated using the non-parametric
Mann–Whitney test; *p ≤ 0.05, **p ≤ 0.01. Note the similar magnitude of cytostatic effects exerted by
bioavailable WMWB and 3%C_WMWB compounds.
Considerable bioactivity of WMWB phenolics remains, in contrast to our previous observations on
the low phenolic content and bioactivity of white bread [24]. However, the lack of correlation between
the bioactivity of the fortified product and the composition/abundance of its bioavailable compounds
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may also result from the relatively low concentration of GCB flour. Consequently, the amounts of
bioactive GCB compounds were too low to effectively contribute to the relatively high cytostatic
activity of WMWB compounds. On the other hand, the final inhibitory effect of the supplemented
product on DU145 proliferation and motility depends on a subtle interplay between the cytostatic and
cytoprotective activities of single WMWB and GCB compounds [9,24]. Accordingly, the cytostatic
potential of GCB compounds can be counteracted by the cytoprotective activities of compounds
donated by WMWB or vice versa. Furthermore, food processing can lead to shifts in the bioavailability
of cytostatic/cytoprotective GCB and WMWB ingredients and to the nonlinearity of cellular reactions
to the extracts [25].
3.3. Bioaccessible WMWB Compounds Interfere with Cytostatic GCB Compounds
To estimate whether gastrointestinal processing can affect the cytoprotective activity of WMWB
compounds, we further compared the phenolic contents and bioactivity of media supplemented with
SB/GD extracts from WMWB and 3%C_WMWB. Analyses of the “gastrointestinal fate” of WMWB
compounds demonstrated that mastication released relatively small amounts of WMWB phenolics
(Figure 3A), which resulted in low antioxidative activity of its SB extract (Figure 3B). Gastrointestinal
digestion of WMWB released only a small fraction of phenolics, including 3-caffeoquinic, syringic,
and vanillic acid; it also slightly increased its inhibitory effect on XO (Figure 3B) and augmented
the cytostatic activity of WMWB extract (Figure 3C). These data suggest that the gastrointestinal
processing of WMWB somehow eliminates cytoprotective WMWB phenolics rather than releasing their
cytostatic counterparts. Consequently, the activity of cytostatic compounds is no longer balanced by
the activity of their cytoprotective counterparts. This notion was further confirmed by the analyses of
the phenolic content and cytostatic activity of the media supplemented with SB and GD 3%C_WMWB
extracts. Gastrointestinal processing considerably increased the phenolic content of 3%C_WMWB
extract (Figure 3A). Concomitantly, gastrointestinal processing increased the XO inhibitory activity
(Figure 3B) and cytostatic properties of GD 3%C_WMWB extract (Figure 3C), without a significant
impact on its anti-invasive activity (Figure 3D). Despite the significant differences in phenolic content
observed upon the processing of both extracts, their cytostatic and antiinvasive effects remained similar.
These observations indicate that the bioaccessible (GD-extractable) compounds of WMWB do not affect
the activity of their cytostatic counterparts but can protect DU145 cells from the cytostatic action of
GCB compounds. Because they are released from the bread matrix by gastrointestinal digestion and
efficiently penetrate simulated intestine barriers in vitro, they can counteract the cytostatic activity
of the bioavailable compounds donated by the fortifier [24–26]. Thus, our data confirm the role of
synergic/antagonistic interactions between the cytostatic and cytoprotective compounds of WMWB
and GCB in determining the fortified product’s bioactivity.
3.4. Gastrointestinal Digestion Attenuates the Activity of Cytoprotective GCB Compounds
To further investigate the effect of WMWB compounds on the nutritional potential of fortified
WMWB, we assessed the “gastrointestinal fate” of bioactive GCB compounds. Masticated (SB) GCB
extract contained an abundant fraction of phenolics (Figure 4A). It was also relatively rich in xanthine
oxidase inhibitors (Figure 4B) and exerted a strong anti-invasive effect on DU145 cells (Figure 4D).
On the other hand, its cytostatic activity was remarkably low (Figure 4C), which may confirm the
presence of cytoprotective compounds in GCB. Gastrointestinal processing considerably reduced the
total amounts of phenolics, caffeine, catechin, and caffeolquinic acids in GCB extract while releasing
considerable amounts of antioxidants and caffeic and ferulic acids (Figure 4A). These shifts in phenolic
content did not affect the strong inhibitory effect of GCB extract on the motility of DU145 cells. In turn,
they were accompanied by increased cytostatic activity of the extract (Figure 4D). These observations
confirm that the cytostatic activity of GCB compounds is retained in GCB extract after gastrointestinal
processing. In addition, differences in proliferation- and motility-related DU145 susceptibility to
the SB, GD, and GDA extracts show that the signaling pathways involved in both processes are
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differentially affected by their compounds. High cytoprotective activity of the hydrophilic fraction
of GCB compounds may account for the relatively low bioactivity of the SB GCB extract. Due to
their relatively low bioaccessibility, they no longer counterbalance the activity of cytostatic GCB
compounds in GD extracts. Gastrointestinal digestion may also attenuate the activity of cytoprotective
GCB compounds in the fortified product. On the other hand, the cytoprotective activity of WMWB
compounds, which counteracts the cytostatic properties of their GCB counterparts, explains the
surprisingly low bioactivity of GCB-fortified WMWB. Bioaccessible WMWB compounds can negatively
affect the cytostatic activity of GCB phenolics in the fortified bread, even though their interference with
the activity of cytostatic WMWB compounds is negligible.
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xanthine oxidase inhibitors (Figure 4B) and exerted a strong anti-invasive effect on DU145 cells 
(Figure 4D). On the other hand, its cytostatic activity was remarkably low (Figure 4C), which may 
confirm the presence of cytoprotective compounds in GCB. Gastrointestinal processing considerably 
reduced the total amounts of phenolics, caffeine, catechin, and caffeolquinic acids in GCB extract 
Figure 3. Gastrointestinal fate of compounds from WMWB and from its variant fortified with 3% GCB
flour. (A) Raw and 3% GCB_WMWB were subjected to simulated mastication (SB) and gastrointestinal
digestion (GD) in vitro, and the extract was applied to culture medium at a concentration equivalent to
250 g of product per 75 kg of body weight. The bar graphs show theoretical medium concentrations of
the compounds calculated on the basis of their content in the extract. (B) GCB were processed as above,
and the antioxidative and XO inhibitory activity of the extracts was estimated. (C) DU145 cells were
seeded at a density of 104/cm2, cultivated for 24 h, and treated with the relevant extract for 72 h, and
cell motility was analyzed via time-lapse videomicroscopy. Cell trajectories are presented in circular
diagrams with the starting point of each trajectory situated at the plot center (N = 50). The bar graph
shows the averaged cell motility. (D) DU145 cells were seeded at a density of 104/cm2 and cultivated
for 24 h before SB and GD extracts of WMWB and of its fortified variant were administered along with
10% fetal bovine serum (FBS)-supplemented culture medium. Cell proliferation was measured after 72
h of incubation using a Coulter counter and compared to the control (=100%). Scale bar: 100 µm. All
results are representative of at least three independent experiments performed in triplicate (N > 9). The
values designated by the different letters (A and B) are statistically significantly different. p-values in
C and D were calculated using the non-parametric Mann–Whitney test; *p ≤ 0.05, **p ≤ 0.01, ***p ≤
0.001.Note the differences between the i acti it f t e SB and GD WMWB extracts and the lack of
such differ nces between GD extracts fro ra its B-fortified variant.
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medium at a concentration equival r uct per 75 kg of body weight. The ba graphs
show theoretical mediu tions of the compounds calculated on the basis of their content
in the extract. (B) GCB w re processed s above, and the antioxidative and XO inhibitory activity of
the extracts was estimated. (C) DU145 cells were see ed at a density of 104/cm2, and cell proliferation
was measured after 72 h of incubation using a oulter counter and compared to the control (= 100%).
Scale bar: 100 µm. (D) DU145 cells were seeded at a density of 104/cm2, cultivated for 24 h, and treated
with the relevant extract for 72 h, and cell motility was analyzed via time-lapse videomicroscopy. Cell
trajectories are presented in circular diagrams with the starting point of each trajectory situated at the
plot center (N = 50). The bar graph shows averaged cell motility. All results are representative of at
least three independent experiments performed in triplicate (N > 9). The values designated by the
different letters (A and B) are statistically significantly different. p-values in C and D were calculated
using the non-parametric Mann–Whitney test; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. Note the relatively low
bioactivity and high phenolic content of the SB GCB extract.
3.5. Prostate Cells Differ in Their Reactivity to Cytostatic/Cytoprotective WMWB/GCB Compounds
Further analyses were performed to estimate how interactions between WMWB and GCB
compounds and their gastrointestinal fate affect the magnitude of their cytostatic effects on human
prostate cancer PC-3 and epithelial Pnt2 cells. In contrast to DU145 cells, which were propagated from
prostate tumor metastasis to the brain, PC3 cells represent an aggressive cell line derived from bone
metastases of human prostate tumors, whereas epithelial prostate Pnt2 cells display a non-transformed
phenotype. Both PC-3 and Pnt2 cells displayed a high susceptibility to GCB extracts, which confirms the
nutritional and chemopreventive potential of GCB. Notably, hydrophilic and bioaccessible compounds
from the GCB-fortified WMWB exerted a less pronounced cytostatic effect on PC-3 and Pnt2 cells than
their WMWB counterparts (Figure 5). Furthermore, both PC-3 and Pnt2 cells showed relatively low
sensitivity to GD and GDA extracts from the fortified bread. These data show that prostate cells differ in
the reactivity to cytostatic/cytoprotective WMWB/GCB compounds. They also confirm the importance
of nonlinear effects of gastrointestinal processing in terms of the cytostatic activity of GCB/WMWB
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phenolics. Consequently, the cytoprotective activities of GCB/WMWB compounds should be taken
into account when considering the pro-healthy effects of WMWB fortification and its significance for
prostate cancer prevention and treatment.
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Figure 5. Cytostatic effects of GCB, WMWB, and its GCB-fortified variant on PC3 and Pnt2 cells. Cells
were seeded at a density of 104/cm2 and cultivated for 24 h before the extracts from GCB, WMWB,
and its fortified variant were administered along with 10% fetal bovine serum (FBS)-supplemented
culture medium. Cell proliferation was measured after 72 h of incubation using a Coulter counter
and compared to the control (= 100%). All results are representative of at least three independent
experiments performed in triplicate (N > 9). p-values were calculated against the relevant WMWB
control using the non-parametric Mann–Whitney test; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. Note that GCB
fortification attenuates the cytostatic activity of WMWB compounds against PC3 and Pnt2 cells.
Targeted and market-driven food fortification leads to the design of new products that meet the
criteria of so-called “functional foods” [27,28]. Food fortification is usually aimed at increasing the
content of health-promoting components in widely consumed products (e.g., bakery products, pastas,
juices). Prospectively, this strategy is expected to prevent the deficiency of pro-healthy compounds
resulting from commercial food processing [29,30] and to reduce the incidence of “civilization
diseases”, including cancer. Here, we have confirmed that GCB contain numerous substances that
can be used for prostate cancer chemoprevention. However, our observations also demonstrate that
gastrointestinal processing of GCB-fortified bread foods may result in shifts in the WMWB/GCB
compound concentrations. These may have profound consequences for the bioactivity of the product;
in particular, they can account for nonlinear correlation between the cytostatic activity of the product
and its phenolic content [31,32].
The interactions between WMWB and GCB compounds, which negatively affect the bioactivity
of GCB-fortified WMWB, may have chemical, physical, and physiologic backgrounds. At the
physico-chemical level, direct interactions between the compounds may be responsible for nonlinear
associations between their concentrations and activity in complex mixtures. These associations lead
to reciprocal synergistic/antagonistic interactions between the compounds of the fortifier and the
carrier that can be translated into differences in their bioactivity and bias the interpretation of in vitro
analyses [31,32]. Concomitantly, the physical properties of cytoprotective compounds (resulting in
matrix cross-linking and precipitation) affect their bioavailability in the specific cell microenvironment.
Changes in this parameter may also result from the interactions of GCB and WMWB phenolics with
gelatinized starch granules and the gluten network of the bread. Bread preparation can additionally
promote the formation of protein cross-links, hydrophobic and ionic interactions, and hydrogen and
covalent bonding between the matrix and phenolics. Additionally, interactions between phenolics
with salivary proline-rich proteins and/or other digestive enzymes and food proteins can differentially
affect the bioaccessibility of cytoprotective and cytostatic WMWB/GCB compounds [24,33].
At the physiological level, food processing, digestion, and serum interactions determine the
final biological effect of WMWB fortification, whereas intrinsic cellular systems are crucial for the
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susceptibility and adaptation of cancer cells to cytostatic stress. The bioactivity of the fortified product
may also be affected by the momentary physiological status of the whole organism, its multicellular
systems, and single cells. Concomitantly, the quality and quantity of gastrointestinal processing is
determined by the physical status of the organism. Furthermore, secular and permanent cellular
phenotypes, in particular, the activity of cellular detoxification systems, is crucial for cell reactivity
to individual compounds and to their mixtures [34,35]. Prostate cancer cells display relatively high
phenotypic heterogeneity. This is manifested by differences in the activity of intracellular signaling
pathways in discrete prostate cancer cell lineages and leads to their different susceptibility levels to the
cytostatic/chemopreventive action of administered compounds. In our hands, the cytoprotective effect
of WMWB compounds prevailed over their possible cytostatic activity in the PC-3 model, which was
not the case for DU145 cells. At the cellular level, the activity of multi-drug-resistant (MDR) systems
can affect the intracellular bioavailability of the compounds. Most importantly, the cytostatic/cytotoxic
properties of phenolic compounds are often interspersed with their cytoprotective activities, and the
final effect is highly dependent on cellular context.
For instance, nutritional antioxidants can perform as synergists to reduce ROS via quenching
free radicals in both their aqueous and lipid phases. Thus, they preserve the genomic stability of
cells [36]. However, ROS are also involved in the physiological regulation of the signaling pathways
which determine cancer cell proliferation and motility [37]. Therefore, the final activity of antioxidants
can vary between growth inhibition and cytoprotection. This is illustrated by the activity of xanthine
oxidase (XO), the products of which act as regulators of cancer cell proliferation and migration [37,38].
Therefore, the XO-inhibiting activity of the extract may add to its overall cytostatic activity. However,
phenolics can also act as scavengers of pro-oxidative XO products (for instance, superoxides) [39], thus
exerting cytoprotective effects on cancer cells.
4. Conclusions
Collectively, we showed that the complex interplay between the cytostatic and cytoprotective
activities of WMWB and GCB compounds may lessen the pro-healthy activity of GCB-fortified WMWB
at the cellular level. This indicates that the application of GCB for WMWB fortification should be
considered with caution. Further studies are necessary to elucidate the mechanism(s) underlying the
specificity of WMWB/GCB effects on prostate cancer and normal cell physiology. They should also
focus on the interactions between individual GCB and WMWB compounds. These issues should be
addressed before the fortification of a specific carrier with a specific supplement is recommended [40].
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